Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
Cullum, Richard L, Lucas, Lauren M, Senfeld, Jared I, Piazza, John T, Neel, Logan T, Whig, Kanupriya, Zhai, Ling, Harris, Mackenzie H, Rael, Cristina C, Taylor, Darby C, Cook, Laura J, Kaufmann, David P, Mill, Christopher P, Jacobi, Megan A, Smith, Forrest T, Suto, Mark, Bostwick, Robert, Gupta, Ram B, David, Allan E, Riese Ii, David J
Published in PloS one (30.12.2020)
Published in PloS one (30.12.2020)
Get full text
Journal Article
Abstract A19: Discovery and characterization of selective and nonselective inhibitors of ErbB4 signaling: Putative targeted melanoma therapeutics
Lucas, Lauren M., Cullum, Richard L., Senfeld, Jared I., Cook, Laura J., Harris, Mackenzie H., Kaufmann, David Z., Rael, Cristina C., Taylor, Darby C., Piazza, John T., Neel, Logan T., Gupta, Ram B., David, Allan E., Riese, David J.
Published in Cancer research (Chicago, Ill.) (01.10.2020)
Published in Cancer research (Chicago, Ill.) (01.10.2020)
Get full text
Journal Article